Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($6.72) earnings per share for the quarter, beating analysts’ consensus estimates of ($8.05) by $1.33, Zacks reports. The firm had revenue of $0.41 million during the quarter, compared to analysts’ expectations of $0.74 million. Singular Genomics Systems had a negative net margin of 3,237.89% and a negative return on equity of 54.70%.
Singular Genomics Systems Trading Down 0.3 %
Shares of NASDAQ:OMIC traded down $0.08 during trading on Wednesday, hitting $22.89. 3,476 shares of the company were exchanged, compared to its average volume of 34,701. The company has a quick ratio of 8.04, a current ratio of 8.77 and a debt-to-equity ratio of 0.05. Singular Genomics Systems has a 12-month low of $5.34 and a 12-month high of $23.41. The firm’s 50 day moving average price is $14.66 and its 200-day moving average price is $11.17.
Singular Genomics Systems Company Profile
Featured Articles
- Five stocks we like better than Singular Genomics Systems
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Rocket Lab is the Right Stock for the Right Time
- Transportation Stocks Investing
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.